§ BIOTECHNOLOGY
USD · Biotechnology

PTCT

PTC THERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.62
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
229 increased/new, 112 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E8.2P/B1877.27
EPS (TTM)7.74
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.12.9M0.0%+1%
RTW INVESTMENTS, LP7.7M5.3%±0%
JANUS HENDERSON GROUP PLC7.2Mn/a+48%
VANGUARD PORTFOLIO MANAGEMENT LLC4.8Mn/an/a
State Street4.3M0.0%+3%
WELLINGTON MANAGEMENT GROUP LLP3.9M0.1%+2%
◇ AC INTELLIGENCE

Top institutional owners for PTCT as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER54.9% · 241 holders
QUALITY / COMPOUNDER27.3% · 27 holders
PASSIVE / INDEX21.2% · 11 holders
DEALER / BANK19.1% · 34 holders
INCOME / DEFENSIVE3.2% · 25 holders
ACTIVIST2.0% · 1 holder
SYSTEMATIC / QUANT1.6% · 8 holders
TACTICAL / MACRO1.1% · 4 holders
DEEP VALUE0.8% · 1 holder
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for PTCT in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention PTCT yet.